Deals wrap: Pfizer mixing medicines

October 12, 2010

People walk past the Pfizer World headquaters in New York, February 3, 2010. REUTERS/Brendan McDermidPfizer has agreed to buy King Pharmaceuticals for $3.6 billion. *View article *View WSJ blog on who’s benefiting from the deal *View Forbes blog on why the deal seems bad for Genzyme

L’Oreal may be bidding for Avon, the Daily Mail reported. Avon shares jumped 6 percent on the news. *View article

The Australia dollar’s surge to 28-year highs could cause  a headache for Foster’s wine business bidders. *View article

Google is investing in a proposed underwater electric cable to join future offshore wind projects to the East Coast power grid. It’s an investment in “a superhighway for clean energy,” according to Google. *View article

A consortium of Chinese companies may make a rival bid for Potash. Andrew Ross Sorkin reports the politically charged subtext is: “Do we really want the Chinese to control the company that has the largest capacity to produce fertilizer?” *View article

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see